Your browser doesn't support javascript.
loading
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat, Manon; Rinaldi, Sabina; Navionis, Anne-Sophie; Romieu, Isabelle; Biessy, Carine; Viallon, Vivian; Olsen, Anja; Tjønneland, Anne; Fournier, Agnès; Severi, Gianluca; Kvaskoff, Marina; Fortner, Renée T; Kaaks, Rudolf; Aleksandrova, Krasimira; Schulze, Matthias B; Masala, Giovanna; Tumino, Rosario; Sieri, Sabina; Grasso, Chiara; Mattiello, Amalia; Gram, Inger T; Olsen, Karina Standahl; Agudo, Antonio; Etxezarreta, Pilar Amiano; Sánchez, Maria-Jose; Santiuste, Carmen; Barricarte, Aurelio; Monninkhof, Evelyn; Hiensch, Anouk E; Muller, David; Merritt, Melissa A; Travis, Ruth C; Weiderpass, Elisabete; Gunter, Marc J; Dossus, Laure.
Afiliación
  • Cairat M; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Rinaldi S; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Navionis AS; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Romieu I; National Institute of Public Health, Centre for Population Health Research, Cuernavaca, Morelos, Mexico City, Mexico.
  • Biessy C; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Viallon V; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
  • Olsen A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Tjønneland A; Department of Public Health, University of Aarhus, Aarhus, Denmark.
  • Fournier A; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Severi G; Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kvaskoff M; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Équipe "Exposome Et Hérédité", CESP UMR1018, 94805, Villejuif, France.
  • Fortner RT; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Équipe "Exposome Et Hérédité", CESP UMR1018, 94805, Villejuif, France.
  • Kaaks R; Department of Statistics, Computer Science and Applications (DISIA), University of Florence, Florence, Italy.
  • Aleksandrova K; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Équipe "Exposome Et Hérédité", CESP UMR1018, 94805, Villejuif, France.
  • Schulze MB; Division of Cancer Epidemiology, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Masala G; Division of Cancer Epidemiology, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Tumino R; Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
  • Sieri S; Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany.
  • Grasso C; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Mattiello A; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Gram IT; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • Olsen KS; Hyblean Association for Epidemiological Research AIRE -ONLUS, Ragusa, Italy.
  • Agudo A; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Via Venezian, Milano, Italy.
  • Etxezarreta PA; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Sánchez MJ; Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.
  • Santiuste C; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Barricarte A; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Monninkhof E; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.
  • Hiensch AE; Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program; Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Muller D; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain.
  • Merritt MA; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain.
  • Travis RC; Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain.
  • Weiderpass E; Centro De Investigación Biomédica En Red De Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain.
  • Gunter MJ; Escuela Andaluza De Salud Pública (EASP), Granada, Spain.
  • Dossus L; Instituto De Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
BMC Med ; 20(1): 118, 2022 04 18.
Article en En | MEDLINE | ID: mdl-35430795
BACKGROUND: Inflammation has been hypothesized to play a role in the development and progression of breast cancer and might differently impact breast cancer risk among pre and postmenopausal women. We performed a nested case-control study to examine whether pre-diagnostic circulating concentrations of adiponectin, leptin, c-reactive protein (CRP), tumour necrosis factor-α, interferon-γ and 6 interleukins were associated with breast cancer risk, overall and by menopausal status. METHODS: Pre-diagnostic levels of inflammatory biomarkers were measured in plasma from 1558 case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. We used conditional logistic regression to estimate the odds ratios (ORs) of breast cancer at blood collection, per one standard deviation increase in biomarker concentration. RESULTS: Cases were diagnosed at a mean age of 61.4 years on average 8.6 years after blood collection. No statistically significant association was observed between inflammatory markers and breast cancer risk overall. In premenopausal women, borderline significant inverse associations were observed for leptin, leptin-to-adiponectin ratio and CRP [OR= 0.89 (0.77-1.03), OR= 0.88 (0.76-1.01) and OR= 0.87 (0.75-1.01), respectively] while positive associations were observed among postmenopausal women [OR= 1.16 (1.05-1.29), OR= 1.11 (1.01-1.23), OR= 1.10 (0.99-1.22), respectively]. Adjustment for BMI strengthened the estimates in premenopausal women [leptin: OR = 0.83 (0.68-1.00), leptin-to-adiponectin ratio: OR = 0.80 (0.66-0.97), CRP: OR = 0.85 (0.72-1.00)] but attenuated the estimates in postmenopausal women [leptin: OR = 1.09 (0.96-1.24), leptin-to-adiponectin ratio: OR = 1.02 (0.89-1.16), CRP: OR = 1.04 (0.92-1.16)]. CONCLUSIONS: Associations between CRP, leptin and leptin-to-adiponectin ratio with breast cancer risk may represent the dual effect of obesity by menopausal status although this deserves further investigation.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Leptina Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Leptina Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Francia